Next generation imaging technology taking nuclear and precision medicine to the next level
Terapet SA, a Geneva-based CERN MedTech spin-off, has developed an innovative platform technology for imaging in nuclear medicine, taking proton therapy and nuclear imaging to the next level.
Terapet’s mission is to use our innovative platform technology to develop integrated imaging solutions, taking proton therapy, nuclear imaging and precision medicine to the next level.
Terapet envisions that its Qualyscan™ and Nuclyscan™ will enable QUALITY and NEW CLINICAL nuclear imaging in every patient’s diagnosis and treatment, making them the first choice for radiotherapy and precision medicine in the near future.